|
|
Diabetes Mellitus, Experimental - Blood
Research News and Information
Definition of 'Diabetes Mellitus, Experimental'Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Common names: Diabetes Mellitus, Experimental; Experimental Diabetes Mellitus; Streptozotocin Diabetes; Diabetes, Streptozotocin; Streptozocin Diabetes; Diabete, Streptozocin; Diabetes, Streptozocin; Streptozocin Diabete; Alloxan Diabetes; Diabetes, Alloxan |
Saturday, November 21, 2009
Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach.
26 Aug 2009
BACKGROUND: Sodium tungstate is known to be an effective anti-diabetic agent, able to increase beta cell mass in animal models of diabetes, although the molecular mechanisms of this treatment and the genes that control pancreas plasticity are yet to ... Read more...
16 Aug 2009
The increasing prevalence of diabetes mellitus worldwide is an issue of major socio-economic concern. Diabetes mellitus is a complex and a multifarious group of disorders that disturbs the metabolism of carbohydrates, fat and protein. Medicinal ... Read more...
Anti-diabetic properties of three common Bidens pilosa variants in Taiwan.
12 Aug 2009
Bidens pilosa L. var. radiata (BPR), B. pilosa L. var. pilosa (BPP), and B. pilosa L. var. minor (BPM) are common variants of a plant often used as a folk remedy for diabetes in Taiwan. However, the three variants are often misidentified and little ... Read more...
Latest indexed articles for 'Diabetes Mellitus, Experimental - Blood'
These are the very latest articles for this heading:
- Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach.
26 Aug 2009 - Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats.
16 Aug 2009 - Anti-diabetic properties of three common Bidens pilosa variants in Taiwan.
12 Aug 2009 - Uncoupling protein 2 regulates reactive oxygen species formation in islets and influences susceptibility to diabetogenic action of streptozotocin.
25 Jul 2009 - Supplementation with magnesium and vitamin E were more effective than magnesium alone to decrease plasma lipids and blood viscosity in diabetic rats.
29 Jun 2009 - Electro-acupuncture improves responsiveness to insulin via excitation of somatic afferent fibers in diabetic rats.
22 Jun 2009 - Antihyperlipidemic effect of Garlip, a polyherbal formulation in streptozotocin induced diabetic rats.
20 Jun 2009 - SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
20 Jun 2009 - Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats.
16 Jun 2009 - Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
14 Jun 2009 - Diabetes is associated with increased sensitivity of alveolar macrophages to urban particulate matter exposure.
4 Jun 2009 - Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.
31 May 2009 - Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in streptozotocin-induced chronic diabetic rats.
30 May 2009 - Effects of insulin-like growth factor-1 and donor age on transplantation of porcine neonatal pancreatic cell clusters.
30 May 2009 - Polyglycolic Acid-islet grafts improve blood glucose and insulin concentrations in rats with induced diabetes.
30 May 2009 - Study on the antidiabetic mechanism of a shark liver peptide, S-8300, in alloxan-induced diabetes.
30 May 2009 - Dynamics of beta-cell turnover: evidence for beta-cell turnover and regeneration from sources of beta-cells other than beta-cell replication in the HIP rat.
24 May 2009 - A rat model of glycaemic variability.
12 May 2009 - Diabetes increases brain damage caused by severe hypoglycemia.
10 May 2009 - Hypoglycemic effect of quassinoids from Brucea javanica (L.) Merr (Simaroubaceae) seeds.
7 May 2009
See a longer list of these articles.
Technical information about 'Diabetes Mellitus, Experimental'
Definition: Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
Descriptor UI: D003921
Alternative terms: Diabetes Mellitus, Experimental; Experimental Diabetes Mellitus; Streptozotocin Diabetes; Diabetes, Streptozotocin; Streptozocin Diabetes; Diabete, Streptozocin; Diabetes, Streptozocin; Streptozocin Diabete; Alloxan Diabetes; Diabetes, Alloxan;
Related Mesh Headings: Mice, Inbred NOD;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; surgery; therapy; transmission; urine; ultrasonography; virology;
Tree Number: C18.452.394.750.074; C19.246.240; E05.598.500.374;
Online Note: use DIABETES MELLITUS, EXPERIMENTAL to search ALLOXAN DIABETES 1966-77
History Note: 78; ALLOXAN DIABETES was heading 1963-77
Technical Notes: index alloxan or streptozocin diabetes as DIABETES MELLITUS, EXPERIMENTAL (IM) + ALLOXAN or STREPTOZOCIN (NIM) only if the chem are particularly discussed; probably in animal so do not use /vet but don't forget check tag ANIMALS; DF: DIABETES MELLITUS EXPER